Anne-Mari Paster's Net Worth
$206 Million
Who is Anne-Mari Paster?
Anne-Mari Paster has an estimated net worth of $206 Million. This is based on reported shares across multiple companies, which include Nuvation Bio Inc., Morphic Holding, Inc., Lexeo Therapeutics, Inc., Kezar Life Sciences, Inc., IMMUNIC, INC., Theseus Pharmaceuticals, Inc., Kronos Bio, Inc., Replimune Group, Inc., and Translate Bio, Inc..
SEC CIK
Anne-Mari Paster's CIK is 0001652863
Past Insider Trading and Trends
2018 was Anne-Mari Paster's most active year for acquiring shares with 14 total transactions. Anne-Mari Paster's most active month to acquire stocks was the month of June. 2018 was Anne-Mari Paster's most active year for disposing of shares, totalling 20 transactions. Anne-Mari Paster's most active month to dispose stocks was the month of June. 2020 saw Anne-Mari Paster paying a total of $14,465,728.85 for 3,815,332 shares, this is the most they've acquired in one year. In 2023 Anne-Mari Paster cashed out on 17,615,532 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Nuvation Bio Inc. (NUVB) Snapshot price: $1.64
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +44.07% | 8.63M |
$10.00 |
—
| 28.21M |
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Morphic Holding, Inc. (MORF) Snapshot price: $37.53
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.97M |
$15.00 |
—
| 2.97M |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Lexeo Therapeutics, Inc. (LXEO) Snapshot price: $17
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.16M |
$11.00 |
—
| 2.16M |
Nov 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kezar Life Sciences, Inc. (KZR) Snapshot price: $0.949
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.39M |
—
|
—
| 1.39M |
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IMMUNIC, INC. (IMUX) Snapshot price: $1.22
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||